雌二醇对去卵巢大鼠骨和生殖系统损伤的修复作用
[Abstract]:In postmenopausal women, due to the decrease of ovarian function, the level of estrogen plummeted, the bone turnover rate in vivo was significantly accelerated, the rate of bone resorption exceeded the rate of bone formation, resulting in bone mass loss and decreased bone mineral density. Osteoporosis caused by increased bone fragility is called postmenopausal osteoporosis (postmenopausal osteoporosis,PMOP). With the sharp decrease of estrogen secretion and accelerated bone loss in postmenopausal women, PMOP has become a high incidence disease which seriously endangers social and public health, and is also a hot and difficult point in international bone disease research. The purpose of this study was to observe the effects of estrogen on bone tissue, uterus and vaginal structure injury in postmenopausal osteoporosis rats, and the effect of estrogen on mastocyte proliferation in bone tissue of osteoporotic rats. To investigate the repair effect of estrogen on bone tissue and reproductive system injury in osteoporotic rats and the possibility of mast cells as the basis for the diagnosis and treatment of postmenopausal osteoporosis. In this study, 3-month-old SD rats were used to establish the rat model of postmenopausal osteoporosis, and then Estradiol was injected intraperitoneally for therapeutic administration. After administration, the rats were killed after cervical dislocated. The indexes of each organ were calculated. The content of serum calcium (Ca) was measured by flame atomic absorption spectrometry, and the levels of estrogen (E2) and alkaline phosphatase (ALP) in serum were measured by ELISA method. Paraffin sections were made after fixation and decalcification of femur, tibia and femoral head. HE staining and toluidine blue staining were performed. Morphometric analysis was carried out by Image-Pro Plus image analysis system, and the number of mastocytes in bone tissue was counted microscopically. The pathological changes of uterus and vagina were observed by HE staining after routine paraffin sections of uterus and vagina, and morphometric analysis was carried out. The results showed that serum Ca, E2, ALP and uterine index in ovariectomy group were significantly lower than those in pseudo-operation group (P 0.05), P < 0.01, P 0.01, P < 0.01, respectively. The percentage of bone trabecular area and the thickness of bone cerebellum in ovariectomy group were significantly lower than those in false operation group (P 0.01), and the distance between bone trabeculae was increased (P 0.01). Compared with the pseudo-operation group, the number of mastocytes in the cross section of the femur and femoral head in the ovariectomy group was significantly increased (P 0.01), the thickness of uterine canal diameter was decreased (P 0.01), the thickness of uterine mucous membrane and the number of uterine gland were decreased (P 0.05), and the thickness of uterine canal diameter was decreased (P < 0.01). The thickness of vaginal mucosa and the number of vessels in muscle layer decreased (P 0.01), the number of vessels in lamina propria decreased (P 0.05), and the above symptoms were relieved after treatment with estridiol. The conclusions are as follows: 3 months old SD rats can successfully establish postmenopausal osteoporosis model 3 months after ovariectomy. Intermittent intraperitoneal injection of estrogen can effectively improve the biochemical indexes of bone metabolism and bone tissue microstructure in ovariectomy osteoporosis rats, and has the effect of preventing and treating postmenopausal osteoporosis. Estradiol can effectively inhibit the proliferation of bone hypertrophic cells in ovariectomy osteoporosis rats, and bone hypertrophic cells are expected to be the basis for the diagnosis and treatment of postmenopausal osteoporosis. Estradiol can effectively alleviate the atrophy of uterus and vagina in ovariectomy osteoporosis rats and repair the reproductive system injury in postmenopausal osteoporosis rats.
【学位授予单位】:陕西理工大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R580
【参考文献】
相关期刊论文 前10条
1 辛薇;祁珊珊;曾海涛;;雌激素对去卵巢骨质疏松大鼠子宫组织形态的影响[J];黑龙江畜牧兽医;2016年15期
2 郑红星;祁珊珊;曾海涛;;葛根异黄酮联合VitD_3对去卵巢骨质疏松大鼠骨组织构造的影响[J];中国骨质疏松杂志;2016年07期
3 赵雨坤;郑康;郭晴晴;樊丹平;何小鹃;吕爱平;;一种基于EDTA脱钙法的改良骨组织脱钙方法[J];中国实验方剂学杂志;2016年11期
4 祁珊珊;王永吉;辛薇;;SD大鼠绝经后骨质疏松疾病动物模型的构建[J];临床与实验病理学杂志;2016年01期
5 祁珊珊;王永吉;庞田田;杨yN琦;吴婕;辛薇;;去卵巢大鼠骨、生殖系统组织病理学与形态计量学观察[J];中国骨质疏松杂志;2015年07期
6 姚国荣;;雌二醇和孕酮对双侧卵巢切除小鼠子宫局部巨噬细胞及M-CSF表达的影响研究[J];中国现代医生;2015年18期
7 祁珊珊;杨yN琦;庞田田;王永吉;;去卵巢法建立SD大鼠绝经后骨质疏松模型手术探讨[J];中国兽医杂志;2014年02期
8 邝志强;张荣华;;运动联合阿仑膦酸钠片对去卵巢大鼠RANKL/OPG平衡及MAPK信号通路的影响[J];第二军医大学学报;2013年08期
9 孙东霞;;绝经后骨质疏松症患者综合治疗前后生活质量分析[J];内蒙古医学杂志;2011年S8期
10 郑家三;夏成;朱玉哲;张洪友;徐闯;;日粮能量水平对奶牛繁殖性能、血浆代谢产物和生殖激素的影响[J];中国奶牛;2011年10期
相关博士学位论文 前1条
1 耿文鑫;抗绝经后骨质疏松蛋白疫苗的实验研究[D];西北大学;2013年
,本文编号:2494961
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2494961.html